Alpha-synuclein facilitates the toxicity of oxidized catechol metabolites: implications for selective neurodegeneration in Parkinson's disease

FEBS Lett. 2006 Apr 3;580(8):2147-52. doi: 10.1016/j.febslet.2006.03.018. Epub 2006 Mar 15.

Abstract

Free radicals, including dopamine (DA)-oxidized metabolites, have long been implicated in pathogenesis of Parkinson's disease (PD). However, the relationships between such oxidative stresses and alpha-synuclein (alpha-S), a major constituent of Lewy bodies, remain unknown. In this study, we established neuronal cells that constitutively express alpha-S and tetracycline-regulated tyrosinase. While tyrosinase overexpression induced apoptosis, co-expression of wild type or A53T mutant human alpha-S with tyrosinase further exacerbated cell death. In this process, the formation of alpha-S oligomers and the reduction in mitochondrial membrane potential were demonstrated. This cellular model may reconstitute the pathological metabolism of alpha-S in the synucleinopathy and provide a useful tool to explore possible pathomechanisms of nigral degeneration in PD.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis
  • Catechols / metabolism*
  • Catechols / toxicity*
  • Cells, Cultured
  • Comet Assay
  • DNA Damage
  • Enzyme Activation
  • Gene Expression
  • Humans
  • Intracellular Membranes
  • Membrane Potentials
  • Mitochondrial Membranes / metabolism
  • Mitogen-Activated Protein Kinases / metabolism
  • Molecular Weight
  • Monophenol Monooxygenase / metabolism
  • Multiprotein Complexes
  • Mutation / genetics
  • Nerve Degeneration / pathology*
  • Oxidation-Reduction
  • Parkinson Disease / metabolism*
  • Parkinson Disease / pathology*
  • alpha-Synuclein / metabolism*

Substances

  • Catechols
  • Multiprotein Complexes
  • alpha-Synuclein
  • Monophenol Monooxygenase
  • Mitogen-Activated Protein Kinases
  • catechol